Dynavax Aims To Disrupt GSK’s Shingrix Market With More Tolerable Shingles Vaccine

Company And Competitors Seek ‘Best-In-Class’ Status

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.